No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis

Annals of Neurology

Volumn 73, Issue 3, 2013, Pages 433-437

  Barizzone, Nadia ^a   Pauwels, Ine ^b   Luciano, Bernadetta ^a   Franckaert, Dean ^b,c   Guerini, Franca Rosa ^d   Cosemans, Leentje ^b   Hilven, Kelly ^b   Salviati, Alessandro ^e   Dooley, James ^b,c   Danso Abeam, Dina ^b   Di Sapio, Alessia ^f   Cavalla, Paola ^g   Decallonne, Brigitte ^b   Mathieu, Chantal ^b   Liston, Adrian ^b   Leone, Maurizio ^a,h   Dubois, Bénédicte ^b   D'Alfonso, Sandra ^a   Goris, An ^b,i  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

^f SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

ⁱ Laboratory for Neuroimmunology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 27B1; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BELGIUM; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RICKETS;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADULT; BELGIUM; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; GENOTYPE; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUTATION; RADIOIMMUNOASSAY; VITAMIN D; YOUNG ADULT;

EID: 84876492894     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23834     Document Type: Article

References (21)

1. The International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
2. Ramagopalan SV, Dyment DA, Cader MZ, et al. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 2011; 70: 881-886.
3. Mathieu C,. Vitamin D and diabetes: the devil is in the D-tails. Diabetologia 2010; 53: 1545-1548.
4. Van Belle TL, Gysemans C, Mathieu C,. Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab 2011; 25: 617-632.
5. van Etten E, Stoffels K, Gysemans C, et al. Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev 2008; 66: S125-S134.
6. The Australia and New Zealand Multiple Sclerosis Genetics Consortium. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-828.
7. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60: 1624-1631.
8. Lopez ER, Zwermann O, Segni M, et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 2004; 151: 193-197.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.
11. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
12. Mathieu C, Van der Schueren BJ,. Vitamin D deficiency is not good for you. Diabetes Care 2011; 34: 1245-1246.
13. Wang X, Zhang MY, Miller WL, Portale AA,. Novel gene mutations in patients with 1alpha-hydroxylase deficiency that confer partial enzyme activity in vitro. J Clin Endocrinol Metab 2002; 87: 2424-2430.
14. Durmaz E, Zou M, Al-Rijjal RA, et al. Clinical and genetic analysis of patients with vitamin D-dependent rickets type 1A. Clin Endocrinol (Oxf) 2012; 77: 363-369.
15. Kim CJ, Kaplan LE, Perwad F, et al. Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency. J Clin Endocrinol Metab 2007; 92: 3177-3182.
16. Torkildsen O, Knappskog PM, Nyland HI, Myhr KM,. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Arch Neurol 2008; 65: 809-811.
17. Wang JT, Lin CJ, Burridge SM, et al. Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet 1998; 63: 1694-1702.
18. Mathieson I, McVean G,. Differential confounding of rare and common variants in spatially structured populations. Nat Genet 2012; 44: 243-246.
19. Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 2004; 53: 1129-1136.
20. Stoffels K, Overbergh L, Giulietti A, et al. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 2006; 21: 37-47.
21. Panda DK, Miao D, Tremblay ML, et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 2001; 98: 7498-7503.